Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional consequences of NOD2 (CARD15) mutations.

Clara Abraham1, Judy H Cho

  • 1Department of Medicine, Section of Gastroenterology, University of Chicago, Chicago, Illinois 60637, USA. cabraham@medicine.bsd.uchicago.edu

Inflammatory Bowel Diseases
|June 29, 2006
PubMed
Summary

Genetic variations in NOD2 (nucleotide-binding oligomerization domain-containing protein 2) are linked to Crohn's disease and immune responses. Further research into NOD2 pathways is crucial for understanding human intestinal inflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exome sequencing directly implicates 68 genes in inflammatory bowel disease.

medRxiv : the preprint server for health sciences·2026
Same author

Reply.

Gastroenterology·2026
Same author

GM-CSF regulates ILC states and myeloid cell signaling during ulceration in Crohn's disease.

bioRxiv : the preprint server for biology·2026
Same author

Genomic Insights Into Inflammatory Bowel Disease in United States Hispanic Participants: An Ancestry-Focused Study.

Gastroenterology·2026
Same author

Automating clinical phenotyping using natural language processing.

Communications medicine·2026
Same author

Postoperative Ileum Transcriptomics Implicate Sex-Biased Mechanisms in Crohn's Disease Recurrence.

Gastroenterology·2025

Area of Science:

  • Immunology
  • Genetics
  • Gastroenterology

Background:

  • Polymorphisms in NOD2 (nucleotide-binding oligomerization domain-containing protein 2) are associated with ileal and ileocolonic Crohn's disease, graft-versus-host disease mortality, and Blau syndrome.
  • NOD2 activation by peptidoglycan initiates signaling pathways, with Crohn's disease-associated mutations linked to reduced NF-kappaB activation.
  • NOD2 plays a role in bacterial defense and immune tolerance within the intestinal system.

Purpose of the Study:

  • To review the current understanding of NOD2 signaling pathways and the functional consequences of its mutations.
  • To explore the complex role of NOD2 in human intestinal inflammation.
  • To identify potential therapeutic targets for Crohn's disease.

Main Methods:

Related Experiment Videos

  • Literature review of studies on NOD2 function, signaling, and mutations.
  • Analysis of NOD2's role in innate immunity and inflammatory responses.
  • Examination of the interplay between NOD2 and other immune pathways, such as Toll-like receptor signaling.

    • Main Results:

    • Significant advancements have been made in defining NOD2 signaling partners, pathways, and the effects of mutations on its activation, expression, and signaling.
    • NOD2's synergistic effects with Toll-like receptor signaling and its antimicrobial functions have been elucidated.
    • The precise contribution of NOD2 to human intestinal inflammation remains complex and not fully understood.

    Conclusions:

    • Understanding NOD2-mediated pathways is critical for unraveling the pathogenesis of Crohn's disease.
    • Further research into NOD2 signaling may reveal novel therapeutic targets for inflammatory bowel diseases.
    • NOD2's multifaceted role in immunity highlights its importance in maintaining intestinal homeostasis.